Evelo Biosciences Inc EVLO

NAS: EVLO | ISIN: US2997341035 29/04/2025

0,001 USD (0,00%)

(0,00%) 29/04/2025

Grafiek Evelo Biosciences Inc

Grafiek Evelo Biosciences Inc

1 dag1d 0,00%
1 week1w 0,00%
1 maand1m 0,00%
3 maanden3m 25,00%
6 maanden6m 25,00%
1 jaar1j -98,95%
5 jaar5j -99,99%

Evelo Biosciences Inc in het nieuws

Toon enkel gratis nieuws

6 november 2023 · Thinking about buying stock in Aldeyra Therapeutics, Alphabet Inc., DraftKings, Evelo Biosciences, or Enlivex Therapeutics? · Persbericht

16 mei 2023 · Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry · Persbericht

11 januari 2023 · Horizon Technology Finance Provides Fourth Quarter 2022 Portfolio Update · Persbericht

28 februari 2022 · Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs · Persbericht

15 februari 2022 · Invaio Sciences Strengthens Its Board Of Directors With The Appointment Of Hugh Grant · Persbericht

13 oktober 2021 · Invaio Sciences Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate Change · Persbericht

25 mei 2021 · Invaio Sciences Raises $88.9 Million to Accelerate the Transition to Biological Agriculture · Persbericht

19 mei 2021 · Invaio Sciences Announces Key Agreement with Fundecitrus in Brazil to Combat Against Citrus Greening · Persbericht

30 maart 2021 · Invaio Sciences Strengthens Leadership Team with Appointment of Peleg Chevion as President and Chief Commercial Officer · Persbericht

9 maart 2021 · Evelo Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results and Business Highlights · Persbericht

Profiel Evelo Biosciences Inc

Gezondheidstechnologie

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe